Physician profile
John R Soderstrom
NPI 1871506931
$982.71
in general payments reported to CMS, 2019-2025
11 companies · $417 in 2025
The $417 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $224 · 2022: $30.14 · 2023: $129 · 2024: $183 · 2025: $417.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $628 · Education: $101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $627.54 |
| Education | $101.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $426.45 | 2021-2025 | Absorica Ld, Winlevi |
| Abbvie INC. | $160.69 | 2021-2025 | |
| Lilly USA, LLC | $96.04 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $52.91 | 2023 | Sotyktu |
| Ucb, INC. | $49.34 | 2023-2025 | Bimzelx, Cimzia |
| Amgen INC. | $46.72 | 2023-2025 | Otezla, Otezla |
| Janssen Biotech, INC. | $42.99 | 2024 | Tremfya |
| Organon LLC | $35.63 | 2025 | Vtama |
| Pfizer INC. | $35.26 | 2023-2025 | |
| Dermavant Sciences, INC. | $21.48 | 2024 | Vtama |
| Genzyme Corporation | $15.20 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Soderstrom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.